2016年肝癌基础与临床研究进展

Advances in basic and clinical research on hepatocellular carcinoma in 2016

肝细胞癌（HCC）仍是全球常见的恶性肿瘤之一，其发病率及病死率持续增长。其早期诊断及有效治疗仍是医学难题。HCC的早期特异诊断与有效治疗技术研发仍是重点。现介绍肝癌特异诊断和靶向治疗分子标志物、主要治疗方案及新兴的机器人辅助肝脏切除术、No—touch射频消融术在HCC治疗中的应用等2016年的新进展。

Hepatocellular carcinoma （HCC） is still one of common malignant cancers worldwide, with increasing incidence and mortality rates. Early diagnosis and effective treatment for HCC remain to be explored. This article introduces the research advances in the early specific diagnosis and effective therapies for HCC in 2016, such as molecular markers in the specific diagnosis and targeted therapy for HCC, main therapeutic regimens, robot-assisted liver resection, and no-touch radiofrequency ablation.